2014-2026 Global Duchenne Muscular Dystrophy Drugs Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
SKU ID :Maia-14770887 | Published Date: 12-Dec-2019 | No. of pages: 128Description
The worldwide market for Duchenne Muscular Dystrophy Drugs is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2026, from X.X million US$ in 2019.
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in
Major Companies Covered
Akashi Therapeutics
BioMarin Pharmaceutical
Taiho Pharmaceutical
Acceleron Pharma
Italfarmaco
Nobelpharma
Eli Lilly
Marathon Pharmaceuticals
Summit Therapeutics
Nippon Shinyaku
Bristol-Myers Squibb
Pfizer
Lexicon Pharmaceuticals
Janssen Pharmaceuticals
Asklepios BioPharmaceuticals
Sarepta Therapeutics
Catabasis Pharmaceuticals
Capricor Therapeutics
Santhera Pharmaceuticals
PTC Therapeutics
Major Types Covered
Exondys51
Translarna
Emflaza
Major Applications Covered
Hospitals
Home care settings
Clinics
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…
2019
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in
Major Region
s, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.Major Companies Covered
Akashi Therapeutics
BioMarin Pharmaceutical
Taiho Pharmaceutical
Acceleron Pharma
Italfarmaco
Nobelpharma
Eli Lilly
Marathon Pharmaceuticals
Summit Therapeutics
Nippon Shinyaku
Bristol-Myers Squibb
Pfizer
Lexicon Pharmaceuticals
Janssen Pharmaceuticals
Asklepios BioPharmaceuticals
Sarepta Therapeutics
Catabasis Pharmaceuticals
Capricor Therapeutics
Santhera Pharmaceuticals
PTC Therapeutics
Major Types Covered
Exondys51
Translarna
Emflaza
Major Applications Covered
Hospitals
Home care settings
Clinics
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…
Years considered for this report:
Historical Years:
2014-2018Base Year:
2019Estimated Year:
2019Forecast Period:
2019-2026TOC
Tables & Figures
Companies
- PRICE
-
$3460$5000Buy Now